Musculoskeletal pain in adolescents with recurrent cephalgia: age and sex features, treatment and prevention

DOI: https://doi.org/10.29296/25877305-2023-11-17
Issue: 
11
Year: 
2023

Yu. Kostyuchenko(1); T. Potupchik(2), Сandidate of Medical Sciences; L. Evert(1, 3), MD; E. Panicheva(2), Сandidate of Medical Sciences
1-Federal Research Center «Krasnoyarsk Scientific Center of the Siberian Branch
of the Russian Academy of Sciences», Research Institute of Medical Problems
of the North
2-Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry
of Health of Russia
3-N.F. Katanov Khakass State University, Ministry of Education and Science
of Russia, Abakan

A review of information about musculoskeletal pain in adolescents is presented: the causes of their development, prevalence, classification, clinical manifestations, treatment and prevention. Included are the results of our own research, which showed the peculiarities of the relationship between the frequency of occurrence and the structure of these types of pathology in adolescents with different variants of the course of recurrent cephalalgia – episodic (rare) and chronic (frequent). Frequent dorsalgia in adolescents is significantly more often associated with chronic cephalgia (32.0%), and rare ones – with episodic (46.9%). Girls have a higher incidence of frequent dorsalgia associated with chronic (37.1 and 14.3%) and episodic (22.2 and 16.4%) cephalgia. The authors come to the conclusion about the need for early diagnosis, prevention and timely treatment of dorsalgia associated in adolescents with chronic and episodic cephalgia, and highlight approaches to the treatment and prevention of musculoskeletal pain in children and adolescents.
Keywords: 
adolescents
musculoskeletal pain
dorsalgia
recurrent cephalgia
chronic.

References: 
  1. Бочанова Е.Н., Гацких И.В., Потупчик Т.В. и др. Сравнительный анализ поливитаминов для детей. Вопросы биологической, медицинской и фармацевтической химии. 2020; 23 (11): 10–5 [Bochanova E.N., Gatskikh I.V., Potupchik T.V. et al. Comparative analysis of multivitamins for children. Problems of biological, medical and pharmaceutical chemistry. 2020; 23 (11): 10–5 (in Russ.)]. DOI: 10.29296/25877313-2020-11-02
  2. Воробьева О.В. Хронические болевые синдромы в клинике нервных болезней: вопросы долговременной аналгезии. Consilium Medicum. 2006; 8 (8): 55–60 [Vorobyeva O.V. Chronic pain syndromes in the clinic of nervous diseases: issues of long-term analgesia. Consilium Medicum. 2006; 8 (8): 55–60 (in Russ.)].
  3. Годзенко А.А., Бадокин В.В. Локальная терапия миофасциального болевого синдрома. РМЖ. Ревматология. 2007; 26: 1998–2003 [Godzenko A.A., Badokin V.V. Local therapy of myofascial pain syndrome. RMJ. Rheumatology. 2007; 26: 1998–2003 (in Russ.)].
  4. Голованова В.А., Парфенов В.А. Лечение скелетно-мышечных болей в период пандемии COVID-19. Клиническая фармакология и терапия. 2022; 31 (1): 24–31 [Golovanova V.A., Parfenov V.A. Treatment of musculoskeletal pain during COVID-19 pandemics. Clinical pharmacology and therapy. 2022; 31 (1): 24–31(in Russ.)]. DOI: 10.32756/0869-5490-2022-1-24-31
  5. Государственный реестр лекарственных средств [Электронный ресурс] [State Register of medicinal products [Electronic resource] (in Russ.)]. URL: https://grls.rosminzdrav.ru/
  6. Данилов А.Б. Боль в спине. Избранные лекции по неврологии II. Под ред. В.Л. Голубева. М., 2012 [Danilov A.B. Back pain. Selected lectures on Neurology II. Ed. by V.L. Golubev. M., 2012 (in Russ.)].
  7. Данилов А.Б., Данилов Ал.Б. Управляй болью. Биопсихосоциальный подход. М.: АММ ПРЕСС, 2012 [Danilov A. B., Danilov Al.B. Manage the pain. Biopsychosocial approach. Moscow: AMM PRESS, 2012 (in Russ.)].
  8. Диагностика и лечение скелетно-мышечных (неспецифических) болей в нижней части спины. Клинические рекомендации, 2021 [Diagnosis and treatment of musculoskeletal (nonspecific) pain in the lower back. Clinical recommendations, 2021 (in Russ.)].
  9. Екушева Е.В. Ламотриджин в терапии хронических болевых синдромов. Медицинский алфавит. 2020; 22: 5–8 [Ekusheva E.V. Lamotrigine in treatment of chronic pain syndromes. Medical alphabet. 2020; 22: 5–8 (in Russ.)]. DOI: 10.33667/2078-5631-2020-22-5-8
  10. Курушина О.В., Шкарин В.В., Ивашева В.В. и др. Проблемы изучения эпидемиологии хронической боли в Российской Федерации. Российский журнал боли. 2022; 20 (3): 31–5 [Kurushina O.V., Shkarin V.V., Ivasheva V.V. et al. Problems of studying the epidemiology of chronic pain in the Russian Federation. Russian Journal of Pain. 2022; 20 (3): 31–5 (in Russ.)]. DOI: 10.17116/pain20222003131
  11. Парфенов В.А. Причины, диагностика и лечение боли в нижней части спины. Неврология, нейропсихиатрия, психосоматика. 2009; 1: 19–22 [Parfenov V.A. Causes, diagnosis and treatment of pain in the lower back. Neurology, neuropsychiatry, psychosomatics. 2009; 1: 19–22 (in Russ.)].
  12. Пилипович А.А., Данилов А.Б. Миофасциальный болевой синдром: от патогенеза к лечению. РМЖ. 2012; 29 [Pilipovich A.A., Danilov A.B. Myofascial pain syndrome: from pathogenesis to treatment. RMJ. 2012; 29 (in Russ.)]. URL: https://www.rmj.ru/articles/bolevoy_sindrom/Miofascialynyy_bolevoy_sindrom_ot_patogeneza_k_lecheniyu/
  13. Пилипович А.А., Данилов Ал.Б. Дифференцированный подход к терапии боли: роль нестероидных противовоспалительных препаратов. Болевой синдром. РМЖ. 2013; 18 [Pilipovich A.A., Danilov Al.B. Differentiated approach to pain therapy: the role of nonsteroidal anti-inflammatory drugs. Pain syndrome. RMJ. 2013; 18 (in Russ.)]. URL: https://www.rmj.ru/articles/bolevoy_sindrom/Differencirovannyy_podhod_k_terapii_boli_roly_nesteroidnyh_protivovospalitelynyh_preparatov/
  14. Подчуфарова Е.В. Скелетно-мышечные боли в спине. РМЖ. 2005; 12: 836–41 [Podchufarova E.V. Musculoskeletal back pain. RMJ. 2005; 12: 836–41 (in Russ.)].
  15. Сергеев А.В., Екушева Е.В. Боль в спине у детей и подростков. РМЖ. 2019; 27 (9): 28–32 [Sergeev A.V., Yakusheva E.V. Back pain in children and adolescents. RMJ. 2019; 27 (9): 28–32 (in Russ.)].
  16. Эверт Л.С., Потупчик Т.В., Костюченко Ю.Р. и др. Постковидные поражения скелетно-мышечной системы у подростков: подходы к фармакотерапии. Врач. 2022; 33 (8): 11–8 [Evert, L. Potupchik T., Kostyuchenko Yu. et al. Post-COVID-19 lesions of the musculoskeletal system in adolescents: approaches to pharmacotherapy. Vrach. 2022; 33 (8): 11–8 (in Russ.)]. DOI: 10.29296/25877305-2022-08-02
  17. Al-Hashel J.Y., Ahmed S.F., Alroughani R. Prevalence of primary headache disorders in Kuwait. Neuroepidemiology. 2017; 48 (3-4): 138–46. DOI: 10.1159/000478892
  18. Backpack safety. American Academy of Pediatrics. URL: http://www.healthychildren.org/English/safety-prevention/atplay/Pages/Backpack-Safety.aspx
  19. Baker R.J., Patel D. Lower back pain in the athlete: common conditions and treatment. Prim Care. 2005; 32 (1): 201–29. DOI: 10.1016/j.pop.2004.11.004
  20. Blume H.K. Childhood headache: a brief review. Pediatr Ann. 2017; 46: e155–65. DOI: 10.3928/19382359-20170321-02
  21. Bohman H., Lаftman S.B., Cleland N. et al. Somatic symptoms in adolescence as a predictor of severe mental illness in adulthood: a long-term community-based follow-up study. Child Adolesc Psychiatry Ment Health. 2018; 12: 42. DOI: 10.1186/s13034-018-0245-0
  22. Burton C., Fink Р., Henningsen Р. et al. Functional somatic disorders: discussion paper for a new common classification for research and clinical use. BMC Med. 2020; 18: 34. DOI: 10.1186/s12916-020-150
  23. Calvo-Muñoz I., Kovacs F.M., Roqué M. et al. Risk Factors for Low Back Pain in Childhood and Adolescence: A Systematic Review. Clin J Pain. 2018; 34 (5): 468–84. DOI: 10.1097/AJP.0000000000000558
  24. Chutko L.S., Kornishina T.L., Surushkina S.Yu. et al. Syndrome of autonomic dysfunction in children and adolescents. Zh Nevrol Psikhiatr Im S.S. Korsakova. 2018; 118 (1): 43–9. DOI: 10.17116/jnevro20181181143-49
  25. Diepenmaat A.C., van der Wal M.F., de Vet H.C. et al. Neck/shoulder, low back, and arm pain in relation to computer use, physical activity, stress, and depression among Dutch adolescents. Pediatrics. 2006; 117 (2): 412–6. DOI: 10.1542/peds.2004-2766
  26. Dunn K.M., Jordan K.P., Mancl L. et al. Trajectories of pain in adolescents: A prospective cohort study. Pain. 2011; 152 (1): 66–73. DOI: 10.1016/j.pain.2010.09.006
  27. Franz C., Mоller N.C., Korsholm L. et al. Physical activity is prospectively associated with spinal pain in children (CHAMPS Study-DK). Sci Rep. 2017; 7 (1): 11598. DOI: 10.1038/s41598-017-11762-4
  28. Friedrichsdorf S.J., Giordano J., Dakoji K.D. et al. Chronic Pain in Children and Adolescents: Diagnosis and Treatment of Primary Pain Disorders in Head, Abdomen, Muscles and Joints (Review). Children (Basel). 2016; 3 (4): 42. DOI: 10.3390/children3040042
  29. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2017; 390 (10100): 1211–859. DOI: 10.1016/S0140-6736(17)32154-2
  30. Hakala P.T., Saarni L.A., Punamäki R.L. et al. Musculoskeletal symptoms and computer use among Finnish adolescents - pain intensity and inconvenience to everyday life: a cross-sectional study. BMC Musculoskelet Disord. 2012; 22: 13–41. DOI: 10.1186/1471-2474-13-41
  31. Harden R.N., Bruehl S., Perez R.S. et al. Validation of proposed diagnostic criteria (the ‘‘Budapest Criteria’’) for complex regional pain syndrome. Pain. 2010; 150 (2): 268–74. DOI: 10.1016/j.pain.2010.04.030
  32. Hebert J.J., Leboeuf-Yde C., Franz C. et al. Pubertal development and growth are prospectively associated with spinal pain in young people (CHAMPS study-DK). Eur Spine J. 2019; 28 (7): 1565–71. DOI: 10.1007/s00586-019-05905-6
  33. Hinton D., Kirk S. Families' and healthcare professionals' perceptions of healthcare services for children and young people with medically unexplained symptoms: a narrative review of the literature. Health Soc Care Community. 2016; 24 (1): 12–26. DOI: 10.1111/hsc.12184
  34. Huguet A., Tougas M.E., Hayden J. et al. Systematic review with meta-analysis of childhood and adolescent risk and prognostic factors for musculoskeletal pain. Pain. 2016; 157 (12): 2640–56. DOI: 10.1097/j.pain.0000000000000685
  35. Jeffries L.J., Milanese S.F., Grimmer-Somers K.A. Epidemiology of adolescent spinal pain: a systematic overview of the research literature. Spine. 2007; 32 (23): 2630–7. DOI: 10.1097/BRS.0b013e318158d70b
  36. Kamper S.J., Yamato T.P., Williams C.M. The prevalence, risk factors, prognosis and treatment for back pain in children and adolescents: An overview of systematic reviews. Best Pract Res Clin Rheumatol. 2016; 30 (6): 1021–36. DOI: 10.1016/j.berh.2017.04.003
  37. Kim H.J., Green D.W. Adolescent back pain. Curr Opin Pediatr. 2008; 2 (1): 37–45. DOI: 10.1097/MOP.0b013e3282f357fe
  38. Kovacs F.M., Abraira V., Peña A. et al. Effect of firmness of mattress on chronic non-specific low-back pain: randomised, double-blind, controlled, multicentre trial. Lancet. 2003; 362 (9396): 1599–604. DOI: 10.1016/S0140-6736(03)14792-7
  39. Leboeuf-Yde C., Kyvik K.O. At what age does low back pain become a common problem? A study of 29,424 individuals aged 12–41 years. Spine (Phila Pa 1976). 1998; 23: 228–34. DOI: 10.1097/00007632-199801150-00015
  40. Maia M.M., Gualano B., Sá-Pinto A.L. et al. Juvenile fibromyalgia syndrome: blunted heart rate response and cardiac autonomic dysfunction at diagnosis. Semin Arthritis Rheum. 2016; 46 (3): 338–43. DOI: 10.1016/j.semarthrit.2016.07.002
  41. Malas N., Ortiz-Aguayo L., Giles Р. et al. Pediatric Somatic Symptom Disorders. Curr Psychiatry Rep. 2017; 19 (2): 11. DOI: 10.1007/s11920-017-0760-3
  42. Mayo N.E., Goldberg M.S., Poitras B. et al. The Ste-Justine Adolescent Idiopathic Scoliosis Cohort Study. Part III: Back pain. Spine (Phila Pa 1976). 1994; 19 (14): 1573–81. DOI: 10.1097/00007632-199407001-00005
  43. Оzkan F., Оzkan N.С., Erkorkmaz U. Trigger point injection therapy in the management of myofascial temporomandibular pain. Agri. 2011; 23 (3): 119–25. DOI: 10.5505/agri.2011.04796
  44. Patriarca A., Di Giuseppe G., Albano L. et al. Use of television, videogames, and computer among children and adolescents in Italy. BMC Public Health. 2009; 9: 139–49. DOI: 10.1186/1471-2458-9-139
  45. Queiroz L.B., Lourenço B., Silva L.E.V. et al. Musculoskeletal pain and musculoskeletal syndromes in adolescents are related to electronic devices. J Pediatr (Rio J). 2018; 94 (6): 673–9. DOI: 10.1016/j.jped.2017.09.006
  46. Silva G.R., Pitangui A.C., Xavier M.K. et al. Prevalence of musculoskeletal pain in adolescents and association with computer and videogame use. J Pediatr (Rio J). 2016; 92 (2): 188–96. DOI: 10.1016/j.jped.2015.06.006
  47. Sood M.R., Matta S.R. Approach to a Child with Functional Abdominal Pain. Indian J Pediatr. 2016; 83 (12-13): 1452–58. DOI: 10.1007/s12098-016-2111-5
  48. Xie Y., Szeto G., Dai J. Prevalence and risk factors associated with musculoskeletal complaints among users of mobile handheld devices: a systematic review. Appl Ergon. 2017; 59: 132–42. DOI: 10.1016/j.apergo.2016.08.020
  49. Yamato T.P., Maher C.G., Traeger A.C. et al. Do schoolbags cause back pain in children and adolescents? A systematic review. Br J Sports Med. 2018; 52 (19): 1241–5. DOI: 10.1136/bjsports-2017-098927
  50. Yang R., Dunn J.F., Su D. et al. Lamotrigine inhibits TRESK regulated by G protein coupled receptor agonist. J Neurosci. 2018; 367: 368–75.